Skip to content
  • Clinical Studies
  • Pharma GMP
  • Pharma Tips
  • Stability Studies
  • Pharma Books
  • Schedule M

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

SOP for Preparation of Inorganic Nanoparticles

Posted on By

SOP for Preparation of Inorganic Nanoparticles

Standard Operating Procedure for Preparation of Inorganic Nanoparticles

1) Purpose

This SOP outlines the procedure for the preparation of inorganic nanoparticles, such as gold, silver, and zinc oxide nanoparticles, which are used in various biomedical, industrial, and environmental applications.

2) Scope

This SOP applies to laboratory personnel responsible for synthesizing inorganic nanoparticles using chemical, physical, or biological methods.

3) Responsibilities

  • Operators: Responsible for preparing inorganic nanoparticles following this SOP.
  • QA: Ensures that the nanoparticles meet the required specifications for size, purity, and stability.

4) Procedure

4.1 Synthesis of Gold Nanoparticles

4.1.1 Chemical Reduction Method

  • 4.1.1.1 Dissolve a gold precursor, such as chloroauric acid, in water and reduce it using a reducing agent (e.g., sodium citrate) under stirring, forming gold nanoparticles.
See also  SOP for Preparation of Liposomal Nanoparticles

4.2 Synthesis of Silver Nanoparticles

4.2.1 Reduction of Silver Nitrate

  • 4.2.1.1 Dissolve silver nitrate in water and reduce it using a suitable reducing agent, such as sodium borohydride or plant extracts, to form silver nanoparticles.

4.3 Purification and Characterization

4.3.1 Purification

  • 4.3.1.1 Purify the nanoparticles by centrifugation or filtration to remove unreacted precursors and by-products.

4.3.2 Particle Size Measurement

  • 4.3.2.1 Measure the particle size using dynamic light scattering (DLS) or transmission electron microscopy (TEM) to ensure the nanoparticles are in the desired size range.

4.4 Storage

4.4.1 Storage Conditions

  • 4.4.1.1 Store the inorganic nanoparticles in sealed containers
at room temperature or 4°C, depending on the material and stability.

5) Abbreviations, if any

  • DLS: Dynamic Light Scattering
  • TEM: Transmission Electron Microscopy

6) Documents, if any

  • Inorganic Nanoparticle Synthesis Logbook

7) References, if any

  • Protocols for synthesis and characterization of inorganic nanoparticles

8) SOP Version

Version 1.0

Annexure

Inorganic Nanoparticle Synthesis Logbook Template

Date Batch Number Nanoparticle Type Particle Size Purity Operator Initials QA Initials
DD/MM/YYYY Batch Number Gold/Silver/ZnO Size in nm Purity (%) Operator Name QA Name
           
See also  SOP for Lyophilization of Nanoparticle-Based Formulations
Nanoparticle Formulation Tags:Nanoparticle biomedical applications SOP, Nanoparticle clinical trial SOP, Nanoparticle encapsulation SOP, Nanoparticle formulation SOP, Nanoparticle handling SOP, Nanoparticle preparation procedure, Nanoparticle production SOP, Nanoparticle quality control SOP, Nanoparticle size optimization SOP, Nanoparticle SOP, Nanoparticle stability testing SOP, Nanoparticle standard operating procedures, Nanoparticle sterilization SOP, Nanoparticle storage SOP, Nanoparticle surface modification SOP, Nanoparticle synthesis SOP, Nanoparticle toxicology SOP, SOP for nanomaterials, SOP for nanoparticle characterization, SOP for nanoparticle drug delivery, SOP for nanoparticle gene delivery, SOP for nanoparticle regulatory compliance, SOP for nanoparticle safety, SOP for nanoparticle scaling, SOP for targeted drug delivery nanoparticles

Post navigation

Previous Post: SOP for Lyophilization of Live Attenuated Vaccines
Next Post: SOP for Formulating Self-Emulsifying Drug Delivery Systems (SEDDS)

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version